ARCA, MARCELLO
 Distribuzione geografica
Continente #
NA - Nord America 84
AS - Asia 78
EU - Europa 44
SA - Sud America 11
AF - Africa 6
Totale 223
Nazione #
US - Stati Uniti d'America 80
SG - Singapore 56
IT - Italia 17
BR - Brasile 11
DE - Germania 10
FI - Finlandia 5
IN - India 4
NL - Olanda 4
BD - Bangladesh 3
CN - Cina 3
GB - Regno Unito 3
CA - Canada 2
EG - Egitto 2
IR - Iran 2
NP - Nepal 2
SE - Svezia 2
TR - Turchia 2
ZA - Sudafrica 2
CZ - Repubblica Ceca 1
DZ - Algeria 1
ES - Italia 1
HK - Hong Kong 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 223
Città #
Singapore 45
Boardman 17
Santa Clara 14
Los Angeles 8
Munich 7
Milan 5
Ashburn 3
Lawrence 3
Princeton 3
Amsterdam 2
Changsha 2
Chennai 2
Des Moines 2
Ghorahi 2
Johannesburg 2
London 2
New York 2
São Paulo 2
Tehran 2
Turku 2
Agadir 1
Amman 1
Ankara 1
Araraquara 1
Aylesbury 1
Berlin 1
Brooklyn 1
Cairo 1
Cedar Knolls 1
Charlemont 1
Chlef 1
Cincinnati 1
Clarksburg 1
College Park 1
Concord 1
Curitiba 1
Eden Prairie 1
Helsinki 1
Hong Kong 1
Indianapolis 1
Jacksonville 1
Jeddah 1
Jijoca de Jericoacoara 1
Kingston 1
Madrid 1
Marília 1
Nuremberg 1
Olomouc 1
Othello 1
Phoenix 1
Porteiras 1
Porto Alegre 1
Querétaro City 1
Rio de Janeiro 1
Santo André 1
Sorrento 1
Suez 1
Tashkent 1
Teverola 1
Toronto 1
Vacaria 1
Wilmington 1
Totale 169
Nome #
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 46
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 22
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy] 21
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 18
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 18
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 17
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 17
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 15
Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries 15
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 13
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 12
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 9
Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 8
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 7
Totale 238
Categoria #
all - tutte 3.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 2 0 0 0 0
2021/20229 0 0 0 2 0 0 1 1 0 3 2 0
2022/20238 6 0 0 0 0 0 0 2 0 0 0 0
2023/202430 0 0 0 1 0 0 1 1 0 2 0 25
2024/2025163 19 3 1 8 11 30 0 2 17 12 21 39
2025/202626 26 0 0 0 0 0 0 0 0 0 0 0
Totale 238